Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson's disease.
Nim S, O'Hara DM, Corbi-Verge C, Perez-Riba A, Fujisawa K, Kapadia M, Chau H, Albanese F, Pawar G, De Snoo ML, Ngana SG, Kim J, El-Agnaf OMA, Rennella E, Kay LE, Kalia SK, Kalia LV, Kim PM.
Nim S, et al.
Nat Commun. 2023 Apr 19;14(1):2150. doi: 10.1038/s41467-023-37464-2.
Nat Commun. 2023.
PMID: 37076542
Free PMC article.